GGrantIndex
Sort

8,912 grants matching sars cov 2

SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs

$203,580
Mary Catherine Cambou · University Of California Los Angeles · K23 · FY2023 · AI

SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs

$203,580
Mary Catherine Cambou · University Of California Los Angeles · K23 · FY2024 · AI

Ultrasensitive Point of Care Antigen Test for Detection of Neisseria Gonorrhoeae Using Plasmonic Flours

$203,504
Sumanth Gandra · Washington University · R21 · FY2023 · AI

SARS-CoV-2: Pathogenesis and Countermeasure Development

$203,488
Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Novel TLR-4 Agonists as Vaccine Adjuvants

$203,485
Alan Thomas Johnson · Hawaii Biotech, Inc. · R43 · FY2023 · AI

Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques

$203,402
Kristina Abel · Duke University · P01 · FY2020 · AI

Programming designer DNA nanostructures for blocking enveloped viral infection

$203,149
Weishan Huang · Louisiana State Univ A&M Col Baton Rouge · R21 · FY2023 · AI

Functionalized lipid inactosomes to bind and clear SARS-CoV-2

$203,125
Daniel A Hammer · University Of Pennsylvania · R21 · FY2023 · AI

The Oropharyngeal Microbiome in COVID-19

$203,125
Ronald G Collman · University Of Pennsylvania · R21 · FY2023 · DE

The role of senescence in severe COVID-19

$203,125
Tobias D. Raabe · University Of Pennsylvania · R21 · FY2025 · AI

MRI: Acquisition of a SEC-MALS Instrument for Research and Teaching at California State University, Sacramento

$203,116
Katherine D Zamboanga · University Enterprises, Incorporated · · FY2022 · MPS

Untangling the mechanisms of initiation and discontinuous RNA synthesis by COVID-19 RdRp

$202,936
Shimon Weiss · University Of California Los Angeles · R21 · FY2022 · AI

Determining factors of transmission and evolution of SARS-CoV-2 in populations at risk

$202,848
Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Prenatal endocrine-disrupting chemicals, pandemic-related stress and social risk in mothers and infants

$202,688
Julie Beth Herbstman · Columbia University Health Sciences · R21 · FY2025 · ES

Influenza & COVID Obstetric and Perinatal Epidemiology Study in India

$202,513
Patricia L Hibberd · Boston University Medical Campus · R01 · FY2025 · HD

Deciphering mechanisms of COVID-19 induced anosmia

$202,500
Stavros Lomvardas · Columbia University Health Sciences · R01 · FY2020 · DC

Tuft Cells Modulate Macrophage Response Following Lung Viral Infection

$202,500
Jianwen Que · Columbia University Health Sciences · R21 · FY2023 · AI

Core--SARS Coronavirus Clone and Reagent

$202,418
Ralph S Baric · Univ Of North Carolina Chapel Hill · P01 · FY2009 · AI

Training in HIV Genomics, Treatment, and Cure Research in Botswana

$202,400
Roger L Shapiro · Harvard University D/B/A Harvard School Of Public Health · D43 · FY2024 · TW

Development of a screening diagnostic for the detection of viruses and bacteria from body fluids that utilizes the unparalleled structural characterization of mass spectrometry

$202,368
Aaron Timperman · University Of Pennsylvania · R21 · FY2024 · AI

Mechanisms of SARS-CoV2 translation initiation and shut-off of cellular protein synthesis

$202,344
Christopher Ulrich Tristram Hellen · Suny Downstate Medical Center · R21 · FY2022 · AI

Clinical subjects and recruitment

$202,302
Albert C Shaw · Yale University · U19 · FY2023 · AI

Longitudinal cohort study of SARS-CoV2 sero-conversion in a malaria-endemic community in Western Kenya

$202,190
Steve Myer Taylor · Duke University · R21 · FY2023 · AI

CODEX System for Automated and Highly Multiplexed Immunofluorescence

$202,170
Kimberly Brown Dahlman · Vanderbilt University Medical Center · S10 · FY2021 · OD

Supplement to "New ACE2 activator and its prodrug as novel therapeutic regents for inflammatory pulmonary diseases"

$202,068
Hongpeng Jia · Johns Hopkins University · R21 · FY2021 · AI